Philip Perera M.D., MBA Vice President & Chief
Dr. Perera joined DNS as Chief Medical Officer in December 2009. He is responsible for the clinical leadership of the organization. Dr. Perera has over 20 years clinical and research experience and has been responsible for the development and approval of small molecule drugs for a variety of CNS and pain disorders. Prior to joining DNS Dr. Perera held senior level clinical, scientific, management and business development positions at GlaxoSmithKline, Pharmacia Upjohn, Jazz Pharmaceuticals, Pfizer and the Parkinson's Institute. He is a graduate of Harvard Medical School and a board certified Psychiatrist. He also holds a Masters degree in Business Administration from Arizona State University. Prior to working in the pharmaceutical industry Dr. Perera was on the faculty of New York Hospital, Cornell Medical College as Chief of Inpatient and Day Treatment Psychiatric Services at North Shore University Hospital, and he was a practicing adult and geriatric psychiatrist. Dr. Perera has published numerous clinical research papers and is a member of the American Society for Experimental NeuroTherapeutics where he sits as a member of their Board of Directors.